Almeda Ventures

Almeda Ventures, established in 2020 and based in Tel Aviv, Israel, is a venture capital firm specializing in HealthTech. The firm focuses on investing in medical devices, digital health, and bio-convergence sectors on a global scale. By leveraging its team's deep expertise and extensive network that includes investors, strategic partners, and medical centers worldwide, Almeda Ventures aims to support the growth and success of its portfolio companies.

Amir Blatt

Partner

Dean Dudkiewicz

Analyst

Shany Steinmetz

Associate

Tzahi Sultan

Partner

Irit Yaniv

Partner

9 past transactions

Augmedics

Series D in 2023
Augmedics is a company that develops augmented reality-guided surgical systems aimed at enhancing the safety and outcomes of surgical procedures. Founded in 2014, the company is headquartered in Yoqneam Ilit, Israel, with an additional office located in Chicago, Illinois. Its flagship product, the xvision-spine (XVS) system, features a head-mounted display that allows surgeons to visualize the patient's anatomy through skin and tissue, significantly improving their ability to navigate during complex surgeries. The system integrates real-time positioning of surgical tools and utilizes illumination to enhance the focus area, providing critical insights and assistance to surgeons throughout the procedure. Augmedics strives to revolutionize surgical treatment by leveraging advanced technology to improve healthcare delivery.

Sensi.AI

Series A in 2021
Sensi.AI develops audio-based care intelligence technology for home care providers, acting as a 24/7 care copilot that analyzes voice data to form a holistic understanding of a senior's physical, emotional, and cognitive needs. The platform aims to improve care quality and operational efficiency by enabling continuous monitoring and alerts, including detection of abnormal patterns that could indicate changes in condition or potential maltreatment, with a focus on supporting families and caregivers in assessing service quality while preserving privacy.

FlexDex

Venture Round in 2021
FlexDex Inc. is a medical device company specializing in minimally invasive surgery (MIS) technology. Founded in 2010 and headquartered in Brighton, Michigan, the company has developed a platform that translates a surgeon's hand, wrist, and arm movements from outside the patient into precise movements of an end-effector inside the body. This innovative approach enhances the capabilities of MIS instruments and endoscopes, providing healthcare professionals with improved dexterity and control during surgical procedures. FlexDex serves its market through a network of distributors both in the United States and internationally.

TailorMed

Venture Round in 2021
TailorMed Medical Ltd., established in 2017 and based in Tel Aviv, Israel, specializes in health IT solutions. The company develops and provides financial navigation technology and systems, designed to streamline and automate financial processes for both patients and healthcare providers. Their offerings include TailorMed Financial Navigation, a platform to manage and automate financial processes; TailorMed Financial Insights, an analytics and reporting dashboard to track and measure key performance indicators; and TailorMed Pharmacy, a platform to simplify drug ordering, tracking, and billing based on patient treatment regimens.

Augmedics

Series C in 2021
Augmedics is a company that develops augmented reality-guided surgical systems aimed at enhancing the safety and outcomes of surgical procedures. Founded in 2014, the company is headquartered in Yoqneam Ilit, Israel, with an additional office located in Chicago, Illinois. Its flagship product, the xvision-spine (XVS) system, features a head-mounted display that allows surgeons to visualize the patient's anatomy through skin and tissue, significantly improving their ability to navigate during complex surgeries. The system integrates real-time positioning of surgical tools and utilizes illumination to enhance the focus area, providing critical insights and assistance to surgeons throughout the procedure. Augmedics strives to revolutionize surgical treatment by leveraging advanced technology to improve healthcare delivery.

Lumen

Venture Round in 2020
Lumen is a company that has developed a portable device and accompanying app that measures an individual's metabolism through a single breath. This technology provides users with real-time insights into their metabolic health, enabling them to receive personalized nutrition recommendations tailored to their unique metabolic data. By using Lumen, individuals can better understand their dietary needs and manage their weight effectively, whether their goals are weight loss, performance optimization, or overall wellness. The company is comprised of a diverse team of scientists, researchers, engineers, and designers dedicated to transforming how people approach their health through improved metabolic awareness.

Nurami

Venture Round in 2020
Nurami Medical Ltd., established in 2014 and based in Haifa, Israel, is a clinical-stage medical device company specializing in the development of innovative solutions for soft tissue repair and regeneration following surgeries. The company's flagship product is a dural substitute patch, designed to replace damaged dura mater during neurosurgeries, promoting enhanced healing and patient recovery. Nurami's technology, based on electrospinning, creates a porous scaffold matrix that facilitates tissue regeneration and incorporates a temperature-sensitive sealant to prevent infections and cerebrospinal fluid leaks. The company aims to address unmet surgical needs and improve patient outcomes across various surgical procedures.

TailorMed

Venture Round in 2020
TailorMed Medical Ltd., established in 2017 and based in Tel Aviv, Israel, specializes in health IT solutions. The company develops and provides financial navigation technology and systems, designed to streamline and automate financial processes for both patients and healthcare providers. Their offerings include TailorMed Financial Navigation, a platform to manage and automate financial processes; TailorMed Financial Insights, an analytics and reporting dashboard to track and measure key performance indicators; and TailorMed Pharmacy, a platform to simplify drug ordering, tracking, and billing based on patient treatment regimens.

BioProtect

Venture Round in 2020
BioProtect specializes in developing and commercializing biodegradable balloon spacers to protect normal tissue during cancer radiation therapy. Its flagship product, ProSpace, has demonstrated superior efficacy and safety in protecting the rectum during prostate cancer radiotherapy. BioProtect's technology platform caters to a wide range of applications for unmet clinical needs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.